General Information of the Compound
| Compound ID |
CP0545011
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[[4-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]phenyl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H24ClN5O
|
||||||||||||||||||
| Molecular Weight |
433.943
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(cc1)N1CCN(Cc2ccc(Cn3nc4ccccn4c3=O)cc2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H24ClN5O/c25-21-8-10-22(11-9-21)28-15-13-27(14-16-28)17-19-4-6-20(7-5-19)18-30-24(31)29-12-2-1-3-23(29)26-30/h1-12H,13-18H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
FEBUIPJWEZWCKO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT01005, D(2) dopamine receptor